Influence of interleukin-1?, tumour necrosis factor alpha and prostaglandin E2 on chondrogenesis and cartilage matrix breakdown in vitro
- 1 January 1995
- journal article
- Published by Springer Nature in Rheumatology International
- Vol. 14 (5) , 191-199
- https://doi.org/10.1007/bf00262297
Abstract
Inflammatory mediators such as the cytokines interleukin-1 (IL-1) or (TNFα), and prostaglandins [predominantly prostaglandin E2 (PGE2)] are generally considered to be involved in the breakdown of cartilage matrix in chondrodestructive diseases, especially rheumatoid arthritis and osteoarthritis. Their mode of action is not yet completely understood. Blastemal cells or differentiated chondroblasts/chondrocytes of limb buds from mouse embryos (day 12) in organoid cultures provide an efficient system to investigate the mechanism of action of these substances. Using recombinant human IL-1β, TNFα and PGE2 alone or together (in pairs) in this culture system, we found that none of these substances alone could affect chondrogenesis. TNFα, however, when combined with IL-1β, proved to be the more potent cytokine causing a transformation of embryonal chondrogenic cells into fibroblast-like cells and thus inhibiting the expression of the cartilage cell phenotype. This might be due to inhibition of both the morphgenetic and cytodifferentiation phases of chondrogenesis. The well-known synergistic interaction between both cytokines seems to be phase limited and may not occur in the postchondrogenesis phase. In addition, our results showed that TNFα alone or combined with PGE2 caused a marked breakdown of the cartilage matrix. These in vitro findings might be useful to elucidate the complexity of interactions between different cytokines and PGE2 involved in cartilage destruction processes in vivo.Keywords
This publication has 53 references indexed in Scilit:
- LOCALIZATION OF INTERLEUKIN-1α, TYPE 1 INTERLEUKIN-1 RECEPTOR AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE SYNOVIAL MEMBRANE AND CARTILAGE/PANNUS JUNCTION IN RHEUMATOID ARTHRITISRheumatology, 1992
- Arthritis induced by interleukin-1 is dependent on the site and frequency of intraarticular injectionClinical Immunology and Immunopathology, 1990
- The effect of tumor necrosis factor α and γ‐interferon on the resorption of human articular cartilage and on the production of prostaglandin e and of caseinase activity by human articular chondrocytesArthritis & Rheumatism, 1989
- Stimulation of procollagenase synthesis parallels increases in cellular procollagenase mRNA in human articular chondrocytes exposed to recombinant interleukin 1β or phorbol esterBiochemical and Biophysical Research Communications, 1987
- Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.The Journal of Experimental Medicine, 1986
- Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.The Journal of Experimental Medicine, 1986
- Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.The Journal of Experimental Medicine, 1985
- The effect of prostaglandins on in vitro limb cartilage differentiationExperimental Cell Research, 1983
- In vitro hexosamine depletion of intact articular cartilage by e‐prostaglandinsArthritis & Rheumatism, 1979
- The secretion of enzymes into the pericellular environmentPhilosophical Transactions of the Royal Society of London. B, Biological Sciences, 1975